Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanqing Ye

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Endocrine Connections|April 4, 2025
Identification of tryptophan metabolism-related biomarkers for nonalcoholic fatty liver disease through network analysisCuihua Jiang, Jianqi Liang, Kaibo Hu, et al.
RSC Advances|August 17, 2022
GC-MS combined with multivariate analysis for the determination of the geographical origin of <i>Elsholtzia rugulosa</i> Hemsl. in Yunnan provinceChaopei Zheng, Sifeng Yang, Dequan Huang, et al.
Chinese Medical Journal|August 22, 2025
Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trialZhiqiang Song, Weihong Wang, Peng Li, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Endocrine Connections|April 4, 2025
Identification of tryptophan metabolism-related biomarkers for nonalcoholic fatty liver disease through network analysisCuihua Jiang, Jianqi Liang, Kaibo Hu, et al.
RSC Advances|August 17, 2022
GC-MS combined with multivariate analysis for the determination of the geographical origin of <i>Elsholtzia rugulosa</i> Hemsl. in Yunnan provinceChaopei Zheng, Sifeng Yang, Dequan Huang, et al.
Chinese Medical Journal|August 22, 2025
Tegoprazan-based versus esomeprazole-based triple therapy plus bismuth for first-line Helicobacter pylori eradication: A nationwide, multicenter, double-blind, double-dummy, randomized controlled trialZhiqiang Song, Weihong Wang, Peng Li, et al.
Pageof 3